School Committee learns more about GLP-1 insurance coverage decision - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Advertise
    • Contact
    • Editorial Staff
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Health/Employee Benefits News
Newswires RSS Get our newsletter
Order Prints
August 30, 2025 Newswires
Share
Share
Post
Email

School Committee learns more about GLP-1 insurance coverage decision

line: Andrew SylviaManchester Ink Link

MANCHESTER, NH – Following outcry from numerous educators during the Manchester Board of School Committee meeting in early August, the August 25th Board of School Committee meeting provided details on why Manchester School District employees no longer have insurance coverage for GLP-1 medications.

GLP-1, short for glucagon-like peptide-1, is a type of medication based on the hormone of the same name that helps regulate blood sugar and appetite by stimulating insulin release and slowing stomach emptying. Originally designed as weight loss drugs due to their ability to decrease appetite, the drugs have become effective tools for individuals battling diabetes as well.

During the August 25 meeting, the board was given a presentation on the decision by Manchester School District Attorney Matt Upton and Tom DeLacey, principal consultant for Workplace Benefits Solutions.

According to DeLacey, the cost of GLP-1 rose tenfold from Fiscal Year 2023 to 2025 and rose five times between Fiscal Year 2024 and 2025. DeLacey added that several health insurance carriers had lost hundreds of millions of dollars due in large part to the drug cost spike and that several nearby local government entities had stopped covering GLP-1 medications for cost reasons as well.

DeLacey went on to share a recent study showed that if these drugs were covered by Medicare, the annual national cost would be approximately $65 billion while the net gain in improved health outcomes would be approximately $18 billion.

"It's just so cost prohibitive, for the return you get, it doesn't make a lot of sense," he said.

If the district were to offer these drugs, DeLacey estimated that it would cost the district an additional $2 million and cost district employees $500,000 more on top of that, leading to an annual insurance premium increase of $540 per year for all district employees. Following a question from Ward 8 Board of School Committee Member Jess Spillers, it was revealed that only 168 of the district's roughly 3,500 employees currently have GLP-1 prescriptions.

DeLacey and Upton told the board that employees were not told that they couldn't obtain the drugs, only that they would no longer be covered under the district's health insurance. Employees could still obtain reimbursement for costs of the pills through health savings accounts, direct sales from manufacturers or other alternatives. It was noted there would be reviews of the drugs' costs in the future to see if they would become more affordable. Ward 2 Board of School Committee Member Sean Parr asked how often these reviews would occur, learning that the reviews would occur every six months. DeLacey said that new pill forms of some of the drugs may become available in 2026, although it was uncertain if this would make the drugs more or less expensive.

Members of the board expressed frustration that they were unable to do more to help the staff members that came forward earlier in the month and appreciated that those staff members brought the issue to their attention.

Ward 4 Board of School Committee Member Leslie Want felt like she had failed the teachers that had spoken out during that meeting and asked district administration to provide employees taking GLP-1 drugs with options available to them. Ward 7 Board of School Committee Member Chris Potter also asked if additional options could be investigated.

Ward 5 Board of School Committee Member Jason Bonilla noted that the health and happiness of staff members is crucial to the district's success, but this decision was a side effect of the school district's current budgetary shortfall.

Board of School Committee Vice Chair Jim O'Connell echoed Bonilla's comments regarding the district's budget situation, noting that members of the board have also eliminated their own health insurance in recent years and built on Want's comments noting that further deliberations falling under exceptions to public meeting law took place during non-public session.

"This was not a decision that was lightly made, it is incredibly difficult to make a cut like this," said O'Connell. "But when we're in a situation where the district does not necessarily have the budget that it needs and was requested, we have to make these kinds of decisions."

Older

Gallego supports bill capping prices for medications

Newer

September 2025 Monthly

Advisor News

  • SEC in ‘active and detailed’ settlement talks with accused scammer Tai Lopez
  • Sketching out the golden years: new book tries to make retirement planning fun
  • Most women say they are their household’s CFO, Allianz Life survey finds
  • MassMutual reports strong 2025 results
  • The silent retirement savings killer: Bridging the Medicare gap
More Advisor News

Annuity News

  • Annexus and Americo Announce Strategic Partnership with Launch of Americo Benchmark Flex Fixed Indexed Annuity Suite
  • Rethinking whether annuities are too late for older retirees
  • Advising clients wanting to retire early: how annuities can bridge the gap
  • F&G joins Voya’s annuity platform
  • Regulators ponder how to tamp down annuity illustrations as high as 27%
More Annuity News

Health/Employee Benefits News

  • Wellpoint taps Rachel Chinetti as president
  • Proposed changes to MA and Part D would harm seniors’ coverage in 2027
  • Pan-American Life Insurance Group Reports Record 2025 Results; Premiums Reached $1.86 Billion and Net Income Totaled $110 Million as Company Enters Its 115th Year
  • LightSpun and Smile America Partners Announce Partnership to Accelerate Dental Provider Enrollment to Expand Treatment for 500K Underserved Kids
  • Lawmakers try again to change ‘reflection in the mirror’ for cancer patients
More Health/Employee Benefits News

Life Insurance News

  • Annexus and Americo Announce Strategic Partnership with Launch of Americo Benchmark Flex Fixed Indexed Annuity Suite
  • LIMRA: Individual life insurance new premium sets 2025 sales record
  • How AI can drive and bridge the insurance skills gap
  • Symetra Partners With Empathy to Offer Bereavement Support to Group Life Insurance Beneficiaries
  • National Life Group Ranked Second by The Wall Street Journal in Best Whole Life Insurance Companies of 2026
More Life Insurance News

- Presented By -

Top Read Stories

More Top Read Stories >

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Elevate Your Practice with Pacific Life
Taking your business to the next level is easier when you have experienced support.

Your Cap. Your Term. Locked.
Oceanview CapLock™. One locked cap. No annual re-declarations. Clear expectations from day one.

Ready to make your client presentations more engaging?
EnsightTM marketing stories, available with select Allianz Life Insurance Company of North America FIAs.

Press Releases

  • RFP #T25521
  • ICMG Announces 2026 Don Kampe Lifetime Achievement Award Recipient
  • RFP #T22521
  • Hexure Launches First Fully Digital NIGO Resubmission Workflow to Accelerate Time to Issue
  • RFP #T25221
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Advertise
  • Contact
  • Editorial Staff
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.
Insurance News | InsuranceNewsNet